SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

US markets settle higher on Monday

17 Nov 2020 Evaluate

The strength on markets came following more upbeat reports on the coronavirus vaccine front, with Moderna (MRNA) reporting positive results from a trial of its vaccine candidate. Moderna said that the trial of its potential coronavirus vaccine has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5 percent. Chief Executive Officer of Moderna -- Stéphane Bancel said ‘this is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible.’ He added ‘all along, we have known that each day matters. This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease.’

On the economic front, New York manufacturing activity unexpectedly expanded at a slower rate in the month of November, according to a report released by the Federal Reserve Bank of New York. The New York Fed said its general business conditions index fell to 6.3 in November from 10.5 in October. While a positive reading still indicates growth in regional manufacturing activity, Street had expected the index to rise to 13.5. Looking ahead, the index for future business conditions held steady at 33.9, suggesting that firms remained optimistic about future conditions.

Dow Jones Industrial Average surged 470.63 points or 1.6 percent to 29,950.44, Nasdaq rose 94.84 points or 0.8 percent to 11,924.13 and S&P 500 was up by 41.76 points or 1.16 percent 3,626.91.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: